Digital Front Door with AI‑Image Analysis & Risk Assessment

For Healthcare Providers, Pharma & CROs

Expedite diagnosis and reduce cost of care for developmental and genetic disorders.

Some services are currently available only in the US.

10000

cases analyzed with
our technology

1000

cases in the
last 3 months

1000

cases in the
last 30 days

1000

HOSPITALS, CLINICS
AND ORGANIZATIONS

AI-POwered image analysis & risk assessment

Early Detection of Developmental
Issues & Genetic Disorders

  • Digital front door and patient retention
  • Decision support tools for diagnosis
  • Care management tools for therapy
  • Personalized therapy options
  • Qualified CRO recruitment

10,000+ Medical Centers, Clinics and Hospitals

From early signs to treatment plans

Supporting the Patient’s Journey Every Step of the Way

FDNA offers a digital front door for healthcare providers, decision support tools for diagnosis and care management tools for therapy

FDNA’s data clearing house offers streamlined interoperability
between patients, pharma, and contract research organizations.

Elevating Healthcare Expertise

Empowering Professionals with AI-based Decision Support and Patient Engagement Tools

Pediatric Specialists

A digital front door with advanced AI tools to aid in diagnosis and manage patient care

  • AI-based decision support tools
  • Patient qualification, engagement, and retention
  • Care management tools

Some services are available only in the US

Genetic Specialists

Enhanced patient evaluation with next-generation phenotyping, and patient engagement tools

  • Face2Gene platform
  • Syndrome matches and professional knowledge base
  • Qualified patient engagement

Some services are available only in the US

Health Services

Patient engagement with advanced AI tools to support diagnosis and care management

  • Patient qualification, engagement, and retention
  • AI-based decision support tools
  • Care management tools

Some services are available only in the US

Pharma Companies

FDNA’s data clearing house offers streamlined connectivity between patients and pharma

  • Customized therapy promotions
  • Qualified patient acquisition
and retention
  • Accelerate research and discovery

Some services are available only in the US

CROs

FDNA offers CROs better access to qualified patients and healthcare providers         

  • Patient recruitment on demand
  • Access to relevant providers
and patients
  • New clinical trial opportunities                      

Some services are available only in the US

Researchers

A wide range of AI tools and
data assets tailored for
medical researchers

  • Facial phenotype comparison
  • Discovery of syndrome phenotypes
  • Clinical features quantification and distribution overview

Some services are available only in the US

Empowering Parents, Providers & Pharma Companies

Connecting Concerned Parents & Patients with Healthcare Providers, Pharma & CROs

 

Bringing medical care closer to where it IS needed

79%

of our users live in rural areas, potentially becoming your new patients

Our technology

AI-Powered Image Analysis & Risk Assessment

As the world leader in AI-powered image analysis to aid in diagnosing developmental & genetic disorders, and rare diseases, FDNA develops the most comprehensive database of relevant phenotypic information, crowdsourced from clinicians, patients, labs, and researchers. This real-world data, along with FDNA’s technologies, help expedite diagnosis and reduce the cost of care.

FDNA’s Multi-Modal Algorithm Framework

FDNA builds a trusted AI framework by integrating various algorithms and cross-referencing outcomes from multiple input modalities, such as image analysis, symptom assessment, natural language processing (NLP), video analysis, and voice analysis, we can achieve a heightened capability in detecting health signals and more robustly cross-validate identified health conditions.

Learn More About FDNA’s Multi-Modal Algorithm Frameworks
  • Deep Gestalt®: An algorithm that maps images to potential syndromes.
  • Gestalt Matcher™: An algorithm to discover new or rare syndromes, and for patient matching.
  • Feature Extraction Algorithm: An algorithm that searches for facial characteristics using images and maps these characteristics to HPO terms.
  • Heat Maps: Provides clinicians with intuitive, visual references for why the Deep Gestalt algorithm matched certain results.
  • Focus Assessment: Guides the user through a post-image analysis assessment when the AI produces two or more high-confidence results. The assessment is utilized to diminish ambiguity between syndromes that exhibit similar dysmorphic signals.
  • Feature Match™: Algorithm utilizing HPOs and syndrome atrophy models, mapped to numerical vectors and syndrome-to-HPO probability score.
  • Clinical Notes Analyzer: An NLP algorithm designed to extract HPOs, biomarkers, and symptoms from health records and clinical notes. It supports both text and voice input.
  • Symptom Assessment: Guides parents through an assessment of their child’s condition, behaviors, symptoms, and physical features and provides content and suggestions for specialist referrals. The assessment uses a statistical matching algorithm between the detected symptoms and potential health conditions.
  • D-Score™: An algorithm that determines face dysmorphology in an image.
  • A-Score™: An algorithm that seeks to identify facial characteristics in autistic syndromic and non-syndromic children. Syndromic children: with a diagnosed genetic condition with specific facial dysmorphology. Non-syndromic: no genetic condition described.
  • Care Match™: An algorithm that matches the patient assessment to relevant healthcare providers, pharma companies and CROs for better access to care and care development.


As reviewed by